 |
 Previous Article | Next Article 
Journal of Neuroscience, Vol 13, 4281-4292, Copyright © 1993 by Society for Neuroscience
Signal transduction events mediated by the BDNF receptor gp 145trkB in primary hippocampal pyramidal cell culture
HN Marsh, WK Scholz, F Lamballe, R Klein, V Nanduri, M Barbacid and HC Palfrey
Department of Pharmacological and Physiological Sciences, University of Chicago, Illinois 60637.
The trkB gene encodes a tyrosine kinase receptor, gp145trkB, for brain-
derived neurotrophic factor (BDNF) and neurotrophin-4 (NT-4). To understand
the role of gp145trkB in the nervous system, we have investigated its
expression in embryonic rat hippocampal pyramidal cell cultures and
examined the effects of BDNF on signal transduction in the primary neurons.
The expression of trkB transcripts was established by PCR analysis and in
situ hybridization. In addition to gp145trkB, the pyramidal neuronal
cultures expressed transcripts specific for the NT-3 receptor gp145trkC,
but not for the high-affinity NGF receptor gp140trk or for p75LNGFR, a
low-affinity receptor for all known members of the NGF family of
neurotrophins including the gp145trkB ligands, BDNF and NT-4. The presence
of gp145trkB receptors in the primary neuronal cultures was confirmed by
immunocytochemical analysis in which > 90% of the cells stained with
affinity-purified polyclonal antibodies to gp145trkB. Immunoblots using
this antibody revealed a single approximately 140 kDa protein in both adult
hippocampus and pyramidal cultures. Addition of recombinant BDNF to these
cultures induced the tyrosine phosphorylation of gp145trkB, as determined
by antiphosphotyrosine staining of gp145trkB immunoprecipitates. Moreover,
BDNF treatment activated the microtubule-associated protein (MAP) kinases,
as determined by an increase in MAP2 phosphorylation in vitro. Both the 41
and 44 kDa forms of MAP kinase were activated by BDNF. BDNF also increased
c-fos expression in over 90% of the cells. These results indicate that
gp145trkB does not require p75LNGFR to form a functional receptor for BDNF
in hippocampal pyramidal neurons.
This article has been cited by other articles:
|
|
|
|
 
M. L. Logrip, P. H. Janak, and D. Ron
Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake
FASEB J,
July 1, 2008;
22(7):
2393 - 2404.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Massa, Y. Xie, T. Yang, A. W. Harrington, M. L. Kim, S. O. Yoon, R. Kraemer, L. A. Moore, B. L. Hempstead, and F. M. Longo
Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death.
J. Neurosci.,
May 17, 2006;
26(20):
5288 - 5300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Cavanaugh, J. Ham, M. Hetman, S. Poser, C. Yan, and Z. Xia
Differential Regulation of Mitogen-Activated Protein Kinases ERK1/2 and ERK5 by Neurotrophins, Neuronal Activity, and cAMP in Neurons
J. Neurosci.,
January 15, 2001;
21(2):
434 - 443.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H Tokuoka, T Saito, H Yorifuji, F Wei, T Kishimoto, and S Hisanaga
Brain-derived neurotrophic factor-induced phosphorylation of neurofilament-H subunit in primary cultures of embryo rat cortical neurons
J. Cell Sci.,
January 3, 2000;
113(6):
1059 - 1068.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. Liu, K. Fukunaga, H. Yamamoto, K. Nishi, and E. Miyamoto
Differential Roles of Ca2+/Calmodulin-Dependent Protein Kinase II and Mitogen-Activated Protein Kinase Activation in Hippocampal Long-Term Potentiation
J. Neurosci.,
October 1, 1999;
19(19):
8292 - 8299.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. A. Gottschalk, H. Jiang, N. Tartaglia, L. Feng, A. Figurov, and B. Lu
Signaling Mechanisms Mediating BDNF Modulation of Synaptic Plasticity in the Hippocampus
Learn. Mem.,
May 1, 1999;
6(3):
243 - 256.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
B. Murray, A. Alessandrini, A. J. Cole, A. G. Yee, and E. J. Furshpan
Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity
PNAS,
September 29, 1998;
95(20):
11975 - 11980.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. T. Baxter, M. J. Radeke, R. C. Kuo, V. Makrides, B. Hinkle, R. Hoang, A. Medina-Selby, D. Coit, P. Valenzuela, and S. C. Feinstein
Signal Transduction Mediated by the Truncated trkB Receptor Isoforms, trkB.T1 and trkB.T2
J. Neurosci.,
April 15, 1997;
17(8):
2683 - 2690.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Furukawa, S. Estus, W. Fu, R. J. Mark, and M. P. Mattson
Neuroprotective Action of Cycloheximide Involves Induction of Bcl-2 and Antioxidant Pathways
J. Cell Biol.,
March 10, 1997;
136(5):
1137 - 1149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kang and E. M. Schuman
A Requirement for Local Protein Synthesis in Neurotrophin-Induced Hippocampal Synaptic Plasticity
Science,
September 6, 1996;
273(5280):
1402 - 1406.
[Abstract]
|
|
|
|
|
|
|
B Berninger, S Marty, F Zafra, M da Penha Berzaghi, H Thoenen, and D Lindholm
GABAergic stimulation switches from enhancing to repressing BDNF expression in rat hippocampal neurons during maturation in vitro
Development,
January 8, 1995;
121(8):
2327 - 2335.
[Abstract]
[PDF]
|
|
|
|
|
